Health and Healthcare

Amgen : AMGN

All Amgen Articles

707 Articles

Lee Jackson | Oct 20, 2016 at 9:55 AM EDT

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

These top biotech companies have been absolutely hammered and now trade at a valuation much lower than large cap pharmaceuticals.

Chris Lange | Oct 12, 2016 at 7:10 AM EDT

Short Sellers Have Mixed Views on Major Biotechs

If a single failed clinical trial can mean disaster for a biotech stock, then short sellers can argue for a…

Chris Lange | Sep 27, 2016 at 7:50 AM EDT

Short Sellers Increase Bets in Major Biotechs

The September 15 short interest data have been compared with the previous report, and short interest moves were upward across…

Jon C. Ogg | Sep 26, 2016 at 8:15 AM EDT

How Much Will Consumers Save on New Humira Biosimilar?

In a time when government wrangling about drug prices is more than commonplace, news of a biosimilar for the mega-blockbuster…

Lee Jackson | Sep 19, 2016 at 8:25 AM EDT

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

An RBC report noted that although headline issues such as the Federal Reserve and the election are increasing volatility, four…

Chris Lange | Sep 13, 2016 at 7:05 AM EDT

Short Sellers Run for Cover From Major Biotechs

The August 31 short interest data have been compared with the previous report, and short interest decreased for most of…

Chris Lange | Aug 25, 2016 at 8:40 AM EDT

Short Sellers Increase Bets in Major Biotechs

The August 15 short interest data have been compared with the previous report, and short interest moves were mixed across…

Chris Lange | Aug 10, 2016 at 8:50 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the July 29 settlement date and short interest decreased across these selected biotech…

Jon C. Ogg | Aug 2, 2016 at 12:35 PM EDT

Why Advaxis Shares Could More Than Double, Even After the Amgen Deal

According to one analyst, Advaxis shares could still easily more than double, even after news broke that biotech giant Amgen…

Lee Jackson | Aug 1, 2016 at 9:25 AM EDT

RBC Says Buy Big Biotechs Now for Possible Big 2016 Gains

Finally, concerns about biotech seem to be waning. An RBC research report notes that at the recent political conventions there…

Chris Lange | Jul 27, 2016 at 11:50 AM EDT

What to Look for in Amgen Earnings

Amgen is expected to report its second-quarter financial results after the markets close on Wednesday. Will it go the same…

Chris Lange | Jul 27, 2016 at 7:50 AM EDT

Major Biotechs See Increased Short Interest Bets

The short interest data are out for the July 15 settlement date. Short interest increased across many of these selected…

Chris Lange | Jul 24, 2016 at 10:12 AM EDT

10 Must-See Earnings for the Coming Week

24/7 Wall St. has put together a preview of Alphabet, Amazon.com, Facebook and some of the other major companies reporting…

Chris Lange | Jul 13, 2016 at 8:10 AM EDT

Short Sellers Become More Selective on Major Biotechs

The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in…

Chris Lange | Jul 12, 2016 at 10:10 AM EDT

Biotechs With Drug Pipelines Closest to Zero Valuation

Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline…

1 … 21 22 23 24 25 … 48

Amgen : AMGN

All Amgen Articles

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

Short Sellers Have Mixed Views on Major Biotechs

Short Sellers Increase Bets in Major Biotechs

How Much Will Consumers Save on New Humira Biosimilar?

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

Short Sellers Run for Cover From Major Biotechs

Short Sellers Increase Bets in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Why Advaxis Shares Could More Than Double, Even After the Amgen Deal

RBC Says Buy Big Biotechs Now for Possible Big 2016 Gains

What to Look for in Amgen Earnings

Major Biotechs See Increased Short Interest Bets

10 Must-See Earnings for the Coming Week

Short Sellers Become More Selective on Major Biotechs

Biotechs With Drug Pipelines Closest to Zero Valuation

Ryanair CFO: Rival Airlines Could Fail This Winter; Industry Shakeout Could Lead to Pricing Power

The Divorce Settlement Mistake Costing Retirees Thousands

3 Reasons I’m Buying Amazon Over and Over Until Late 2026

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

If You Just Inherited an IRA, Read This

If I Could Only Own 1 ETF for the Rest of 2026, It Would Be This One

Ryanair CFO: Rival Airlines Could Fail This Winter; Industry Shakeout Could Lead to Pricing Power

Amgen : AMGN

All Amgen Articles

Mega-Cap Biotechs Cheapest in Years: 4 to Buy for 2017 Gains

Short Sellers Have Mixed Views on Major Biotechs

Short Sellers Increase Bets in Major Biotechs

How Much Will Consumers Save on New Humira Biosimilar?

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

Short Sellers Run for Cover From Major Biotechs

Short Sellers Increase Bets in Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Why Advaxis Shares Could More Than Double, Even After the Amgen Deal

RBC Says Buy Big Biotechs Now for Possible Big 2016 Gains

What to Look for in Amgen Earnings

Major Biotechs See Increased Short Interest Bets

10 Must-See Earnings for the Coming Week

Short Sellers Become More Selective on Major Biotechs

Biotechs With Drug Pipelines Closest to Zero Valuation

Ryanair CFO: Rival Airlines Could Fail This Winter; Industry Shakeout Could Lead to Pricing Power

The Divorce Settlement Mistake Costing Retirees Thousands

3 Reasons I’m Buying Amazon Over and Over Until Late 2026

Featured Reads

The Roth Conversion Window That Closes Faster Than Most 401(k) Savers Expect

If You Just Inherited an IRA, Read This